Progression of disease within 24 months (POD24) in follicular lymphoma in the rituximab era: incidence, clinicopathological risk factors, and outcome in a population-based Danish cohort

oleh: Marie Hairing Enemark, Jonas Klejs Hemmingsen, Maja Dam Andersen, Trine Engelbrecht Hybel, Mads Emil Bjørn, Pär Lars Josefsson, Lars Møller Pedersen, Maja Bech Juul, Robert Schou Pedersen, Michael Thorsgaard, Ida Blok Sillesen, Trine Lindhardt Plesner, Stephen Jacques Hamilton-Dutoit, Paw Jensen, Charlotte Madsen, Maja Ludvigsen

Format: Article
Diterbitkan: Nature Publishing Group 2024-09-01

Deskripsi

No description available for this item.